Assessment of Renal Function in Post-Liver Transplant HCV-Positive Patients Treated with Direct Acting Antivirals.
Khaled Mohamed Amin ElzorkanyMahmoud Abd-Elaziz KoraAliaa Sabry Abdel WahedHassan El-Sayed ZaghlaAhmed Mohamed ZahranYassein Salah YasseinAsmaa Zaki El NaggarAbdallah EssaAbdelnaser Abdelaty GadallahPublished in: International journal of nephrology and renovascular disease (2020)
DDAs in post-liver transplant patients with HCV infection were well tolerated and associated with stable renal function. Moreover, sofosbuvir plus daclatasvir regimen showed relatively better renal safety compared to sofosbuvir plus ribavirin.